IL6 and COVID-19: Targeting the appropriate cytokine is one of the main objectives of current studies, and one of the first approaches to COVID-19 cytokine storm syndrome treatment was targeting the IL-6, since early during the pandemic, IL-6 concentrations were noted to be elevated.